Transforming Neuroscience Through Digital Biomarkers

We exist to improve people’s lives by empowering healthcare professionals and clinical research teams via innovative mobile platforms powered by artificial intelligence

Transforming Neuroscience Through Digital Biomarkers

We exist to improve people’s lives by empowering healthcare professionals and clinical research teams via innovative mobile platforms powered by artificial intelligence

Establishing a new standard in precision Neuroscience

Healios AG is a Medical Device Software Manufacturer that is dedicated to finding solutions in clinical research and patient monitoring through innovative digital technologies

With novel, validated and patented Digital Biomarkers, we aim at measuring – with unprecedented sensitivity – changes in motor and cognitive functions in patients with neurological disorders

These novel biomarkers will establish a new standard for both pharmacological research and clinical practice

We believe …

We believe …

We believe that patients are asking for change in the way their illnesses are diagnosed and monitored

We believe new, better treatment can be discovered and brought to market much more efficiently through the smart use of ubiquitous mobile technologies

We believe that mobile technologies can seamlessly connect patients with their treatment teams to achieve improved outcomes

Bringing value to both patients and healthcare professionals

Working with patients, caregivers and healthcare professionals we identified various challenges they experience every day.
Our solution improves the whole patient/HCP relationship and creates opportunities for novel insights and a timely change in diagnosis and disease management

A foundation of significant achievements to fulfill our vision

  • 2015
    Collaboration with Jansen Pharma on Schizophrenia
  • 2016
    Collaboration with Roche in Alzheimer’s
  • 2017
    Collaboration with Genentech & Roche in Multiple Sclerosis
  • 2018
    Awarded ‘Seal of Excellence’ by the European leading research program ‘Horizon 2020’
  • 2019
    Collaboration with University Hospital of Basel in Multiple Sclerosis and awarded Swiss Innovation Award
  • 2020
    Collaboration with RC2NB in Multiple Sclerosis
  • 2021

Contact us to find out more about
our software medical device solution

Contact us to find out more about our
software medical device solution